Robot-assisted radical prostatectomy in prostate cancer

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Robot-assisted radical prostatectomy (RARP) has become the dominant surgical approach for prostate cancer in the USA since 2000.
• The widespread adoption of RARP occurred despite limited data from prospective randomized trials comparing it to open radical prostatectomy (ORP).

Purpose of the Study:

• To evaluate the comparative effectiveness of RARP versus ORP.
• To analyze oncological and functional outcomes of RARP compared to ORP.

Main Methods:

• Review of retrospective institutional and large population-based cohort studies.
• Analysis of perioperative and long-term functional and cancer control outcomes.

Main Results:

• RARP demonstrates superior perioperative and long-term functional outcomes compared to ORP after an adequate learning curve.
• Cancer control outcomes are comparable between RARP and ORP.
• Robotic surgery is associated with substantially higher costs.

Conclusions:

• RARP offers significant functional benefits over ORP for prostatectomy.
• The oncological efficacy of RARP is equivalent to ORP.
• Cost-effectiveness remains a critical factor in the RARP vs. ORP debate.